caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619162435

Praveen VikasMD

Medical OncologyFairfield, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Praveen Vikas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 17 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
JEFFERSON COUNTY HOSPITAL3524,581
RCHP OTTUMWA LLC144653
Elvin Mccarl
Diagnostic Radiology · Ottumwa, IA
59154
STATE UNIVERSITY OF IOWA56316
Iowa Pathology Associates Pc
Clinical Laboratory · Des Moines, IA
4396
Edward Ortell
General Surgery · Ottumwa, IA
28149
Akhtar Ashraf
Diagnostic Radiology · Ottumwa, IA
2544
TENGLIN, RICHARD2267
Kent Walker
Dermatology · Ottumwa, IA
2170
Mudassir Malik
Cardiology · Des Moines, IA
2046
BLEW, STANLEY1549
David Jensen
Diagnostic Radiology · Cedar Rapids, IA
1329
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
90
Unique beneficiaries
—
Total services
185
Distinct HCPCS
2
Medicare payment
$10K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 34 Medical Oncology providers in IA — bottom quintile (cohort median 1,109).
PRESCRIBING · PART D · 2024
Total Rx claims
935
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
25
Brand share
14.4%
Top prescribed drugs
Anastrozole193 claims
Tamoxifen Citrate105 claims
Letrozole85 claims
Prednisone62 claims
Dexamethasone47 claims
QUALITY · MIPS · 2024
Final MIPS score
80.0
Quality
75.7
Cost
72.3
Improvement activities
40.0
Promoting interop.
78.0
Payment adjustment
0.21%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
4
By payment type
Consulting Fee$3K
Food and Beverage$135